
Evonik's 9 November EuroTier announcement described Lypron, a recently launched rumen-protected lysine for dairy cows, and previewed ZyneXtra, an enzyme solution for variable non-starch polysaccharides with a planned launch in the first quarter of 2027. The EuroTier fair in Hanover ran 10–13 November.
The product stages differ: Lypron is an available amino-acid product, while ZyneXtra is a future offer, so buyers should not treat the preview as commercial supply. The story has little direct effect on lysine prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.